Eftal Murat Bakirci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eftal Murat Bakirci has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Husnu Degirmenci
Department of Cardiology, Mengücek Gazi Education and Research Hospital, Erzincan University, Erzincan, Turkey
8 shared publications Hikmet Hamur
Department of Cardiology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey
6 shared publications- Hikmet Hamur
Department of Cardiology, Faculty of Medicine, Erzincan University, Erzincan, Turkey
5 shared publications Husnu Degirmenci
Department of Cardiology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey
5 shared publicationsHakan Duman
Faculty of Medicine, Recep Tayyip Erdoğan University, Rize
4 shared publications- Hakan Duman
Department of Cardiology, Recep Tayyip Erdoğan University Faculty of Medicine, Rize, Turkey
4 shared publications
Latest Publications
- Open Access
- 18 September 2024
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 30, e945832
Uric Acid to Albumin Ratio as a Predictive Marker for Intracoronary Thrombus Severity in ST-Segment Elevation Myocardial Infarction (STEMI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)
BACKGROUND:This study assessed the association between a novel inflammatory marker, uric acid (UA)-to-albumin ratio (UAR), and preprocedural intracoronary artery thrombus (ICAT) in ST elevation myocardial infarction (STEMI). MATERIAL AND METHODS:A total of 171 STEMI patients treated by primary percutaneous coronary intervention between February and December 2023 were evaluated prospectively in this cross-sectional study. The patients were stratified into 2 groups as low (grades 1 to 3) and high-(ICAT) groups (grades 4 and 5). To determine the independent predictors of lower and higher ICAT, multivariate regression analysis was performed. RESULTS:C-reactive protein (CRP), UA, and UAR were significantly higher in the high ICAT group (1.11 (0.3-2.8) vs 0.80 (0.10-2.8), P=0.037; 5.4 (3.5-7.2) vs 4.9 (3.4-5.6), P<0.001; 1.78 (0.82-3) vs 1.48 (0.77-2.57), P<0.001, respectively). However, albumin levels were similar between groups (3.1 (2.1-4.4) vs 3.3 (2.1-4.4), P=0.243). Higher UAR (OR: 3.95% CI: 1.23-12.7, P=0.021), lower left ventricular ejection fraction (LVEF) (OR=0.802; 95% CI 0.7537-0.872; P<0.001), longer pain-wire crossing time (OR=1; 95% CI: 1-1.02; P<0.001), and diabetes mellitus (OR=0.181; 95% CI 0.46-0.7; P<0.001) were independent predictors of ICAT. CONCLUSIONS:UAR, a marker of inflammation, is an independent predictor of ICAT in patients with STEMI.
- 18 September 2024
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 30, e945832
Open AccessUric Acid to Albumin Ratio as a Predictive Marker for Intracoronary Thrombus Severity in ST-Segment Elevation Myocardial Infarction (STEMI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)
BACKGROUND:This study assessed the association between a novel inflammatory marker, uric acid (UA)-to-albumin ratio (UAR), and preprocedural intracoronary artery thrombus (ICAT) in ST elevation myocardial infarction (STEMI). MATERIAL AND METHODS:A total of 171 STEMI patients treated by primary percutaneous coronary intervention between February and December 2023 were evaluated prospectively in this cross-sectional study. The patients were stratified into 2 groups as low (grades 1 to 3) and high-(ICAT) groups (grades 4 and 5). To determine the independent predictors of lower and higher ICAT, multivariate regression analysis was performed. RESULTS:C-reactive protein (CRP), UA, and UAR were significantly higher in the high ICAT group (1.11 (0.3-2.8) vs 0.80 (0.10-2.8), P=0.037; 5.4 (3.5-7.2) vs 4.9 (3.4-5.6), P<0.001; 1.78 (0.82-3) vs 1.48 (0.77-2.57), P<0.001, respectively). However, albumin levels were similar between groups (3.1 (2.1-4.4) vs 3.3 (2.1-4.4), P=0.243). Higher UAR (OR: 3.95% CI: 1.23-12.7, P=0.021), lower left ventricular ejection fraction (LVEF) (OR=0.802; 95% CI 0.7537-0.872; P<0.001), longer pain-wire crossing time (OR=1; 95% CI: 1-1.02; P<0.001), and diabetes mellitus (OR=0.181; 95% CI 0.46-0.7; P<0.001) were independent predictors of ICAT. CONCLUSIONS:UAR, a marker of inflammation, is an independent predictor of ICAT in patients with STEMI.
- 6 June 2022
- Published by Academician Publishing
Kardiyak Aritmiler
Kardiyak aritmiler günlük hayatta sıkça karşılaşılan, hastanın yaşam kalitesinin bozulmasına ve hayatını kaybetmesine yol açan ciddi problemlerden biridir. Bu nedenle kardiyak aritmi konusunu güncel bilgiler kılavuzluğunda derleme ve kitap oluşturma ihtiyacı hissettik. Kardiyak aritmiler kitabı, taze yürekler olan asistanlarımızın da taze heyecanlarını paylaştıkları ilk kitap olması dolayısıyla ayrı bir önem taşımaktadır. Bu açıdan da asistanlarımıza ömür boyu mutluluklar ve başarılar diliyorum. Kardiyak Aritmiler kitabının mevcut haliyle öğrencilerimize, asistanlarımıza ve diğer tüm meslektaşlarımıza faydalı olacağı düşüncesindeyiz. Bu düşünceyle tüm insanlığa faydalı olmasını temenni ediyorum.
- 6 June 2022
- Published by Academician Publishing
Kardiyak Aritmiler
Kardiyak aritmiler günlük hayatta sıkça karşılaşılan, hastanın yaşam kalitesinin bozulmasına ve hayatını kaybetmesine yol açan ciddi problemlerden biridir. Bu nedenle kardiyak aritmi konusunu güncel bilgiler kılavuzluğunda derleme ve kitap oluşturma ihtiyacı hissettik. Kardiyak aritmiler kitabı, taze yürekler olan asistanlarımızın da taze heyecanlarını paylaştıkları ilk kitap olması dolayısıyla ayrı bir önem taşımaktadır. Bu açıdan da asistanlarımıza ömür boyu mutluluklar ve başarılar diliyorum. Kardiyak Aritmiler kitabının mevcut haliyle öğrencilerimize, asistanlarımıza ve diğer tüm meslektaşlarımıza faydalı olacağı düşüncesindeyiz. Bu düşünceyle tüm insanlığa faydalı olmasını temenni ediyorum.
- 17 May 2021
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 37 (10) , 2881-2889
Predictors of left atrial remodeling in newly diagnosed hypertensive patients: a speckle-tracking echocardiographic study
Endothelial dysfunction, oxidative stress, and increased inflammatory activity are the main pathophysiological mechanisms responsible for cardiac remodeling secondary to hypertension. Bilirubin has anti-oxidant, anti-inflammatory, and anti-fibrotic functions. This report’s objectives are to determine whether Query identifiers of left atrial (LA) remodeling, total atrial conduction time (TACT) and LA reservoir strain (LARS), are associated with serum total bilirubin levels, and to identify the possible predictors of LA remodeling in newly diagnosed hypertensive subjects. One hundred thirty-four subjects were enrolled in this study. TACT was evaluated by tissue Doppler imaging, and LARS was calculated by speckle-tracking echocardiography. Laboratory parameters were recorded. The subjects were classified into two separate groups according to the median value of TACT and LARS. In patients with supramedian TACT, LA volume index (LAVI) and epicardial adipose tissue (EAT) thickness were higher, while LARS and LVGLS were lower. In subjects with inframedian LARS, TACT was longer, LAVI and EAT thickness were higher, and LVGLS was lower. Patients with supramedian TACT and inframedian LARS were older and had lower total bilirubin. Total bilirubin, EAT thickness, and age were predictors of TACT and LARS. Serum bilirubin levels may have a protective effect on the LA remodeling process in newly diagnosed hypertensive subjects.
- 17 May 2021
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 37 (10) , 2881-2889
Predictors of left atrial remodeling in newly diagnosed hypertensive patients: a speckle-tracking echocardiographic study
Endothelial dysfunction, oxidative stress, and increased inflammatory activity are the main pathophysiological mechanisms responsible for cardiac remodeling secondary to hypertension. Bilirubin has anti-oxidant, anti-inflammatory, and anti-fibrotic functions. This report’s objectives are to determine whether Query identifiers of left atrial (LA) remodeling, total atrial conduction time (TACT) and LA reservoir strain (LARS), are associated with serum total bilirubin levels, and to identify the possible predictors of LA remodeling in newly diagnosed hypertensive subjects. One hundred thirty-four subjects were enrolled in this study. TACT was evaluated by tissue Doppler imaging, and LARS was calculated by speckle-tracking echocardiography. Laboratory parameters were recorded. The subjects were classified into two separate groups according to the median value of TACT and LARS. In patients with supramedian TACT, LA volume index (LAVI) and epicardial adipose tissue (EAT) thickness were higher, while LARS and LVGLS were lower. In subjects with inframedian LARS, TACT was longer, LAVI and EAT thickness were higher, and LVGLS was lower. Patients with supramedian TACT and inframedian LARS were older and had lower total bilirubin. Total bilirubin, EAT thickness, and age were predictors of TACT and LARS. Serum bilirubin levels may have a protective effect on the LA remodeling process in newly diagnosed hypertensive subjects.
- Open Access
- 30 April 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (5) , 294-303
Time delays in each step from symptom onset to treatment in acute myocardial infarction: Results from a nation-wide TURKMI registry
In this study, we aimed to analyze the TURKMI registry to identify the factors associated with delays from symptom onset to treatment that would be the focus of improvement efforts in patients with acute myocardial infarction (AMI) in Turkey. The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of 24/7 primary percutaneous coronary intervention (PCI). All consecutive patients (n=1930) with AMI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefined 2-week period between November 1, 2018, and November 16, 2018. All the patients were examined in detail with regard to the time elapsed at each step from symptom onset to initiation of treatment, including door-to-balloon time (D2B) and total ischemic time (TIT). After excluding patients who suffered an AMI within the hospital (2.6%), the analysis was conducted for 1879 patients. Most of the patients (49.5%) arrived by self-transport, 11.8% by emergency medical service (EMS) ambulance, and 38.6% were transferred from another EMS without PCI capability. The median time delay from symptom-onset to EMS call was 52.5 (15-180) min and from EMS call to EMS arrival 15 (10-20) min. In ST-segment elevation myocardial infarction (STEMI), the median D2B time was 36.5 (25-63) min, and median TIT was 195 (115-330) min. TIT was significantly prolonged from 151 (90-285) min to 250 (165-372) min in patients transferred from non-PCI centers. The major significant factors associated with time delay were patient-related delay and the mode of hospital arrival, both in STEMI and non-STEMI. The baseline evaluation of the TURKMI study revealed that an important proportion of patients presenting with AMI within 48 hours of symptom onset reach the PCI treatment center later than the time proposed in the guidelines, and the use of EMS for admission to hospital is extremely low in Turkey. Patient-related factors and the mode of hospital admission were the major factors associated with the time delay to treatment.
- 30 April 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (5) , 294-303
Open AccessTime delays in each step from symptom onset to treatment in acute myocardial infarction: Results from a nation-wide TURKMI registry
In this study, we aimed to analyze the TURKMI registry to identify the factors associated with delays from symptom onset to treatment that would be the focus of improvement efforts in patients with acute myocardial infarction (AMI) in Turkey. The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of 24/7 primary percutaneous coronary intervention (PCI). All consecutive patients (n=1930) with AMI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefined 2-week period between November 1, 2018, and November 16, 2018. All the patients were examined in detail with regard to the time elapsed at each step from symptom onset to initiation of treatment, including door-to-balloon time (D2B) and total ischemic time (TIT). After excluding patients who suffered an AMI within the hospital (2.6%), the analysis was conducted for 1879 patients. Most of the patients (49.5%) arrived by self-transport, 11.8% by emergency medical service (EMS) ambulance, and 38.6% were transferred from another EMS without PCI capability. The median time delay from symptom-onset to EMS call was 52.5 (15-180) min and from EMS call to EMS arrival 15 (10-20) min. In ST-segment elevation myocardial infarction (STEMI), the median D2B time was 36.5 (25-63) min, and median TIT was 195 (115-330) min. TIT was significantly prolonged from 151 (90-285) min to 250 (165-372) min in patients transferred from non-PCI centers. The major significant factors associated with time delay were patient-related delay and the mode of hospital arrival, both in STEMI and non-STEMI. The baseline evaluation of the TURKMI study revealed that an important proportion of patients presenting with AMI within 48 hours of symptom onset reach the PCI treatment center later than the time proposed in the guidelines, and the use of EMS for admission to hospital is extremely low in Turkey. Patient-related factors and the mode of hospital admission were the major factors associated with the time delay to treatment.
- Open Access
- 8 January 2021
- Published by SAGE Publications in Angiology
- Vol. 72 (5) , 492
The CHA2DS2-VASc Score and Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention
- 8 January 2021
- Published by SAGE Publications in Angiology
- Vol. 72 (5) , 492
Open AccessThe CHA2DS2-VASc Score and Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention
- Open Access
- 5 November 2020
- Published by SAGE Publications in Angiology
- Vol. 74 (1) , 97
The Association Between C-Reactive Protein/Albumin Ratio and Severity of Carotid Artery Stenosis
- 5 November 2020
- Published by SAGE Publications in Angiology
- Vol. 74 (1) , 97
Open AccessThe Association Between C-Reactive Protein/Albumin Ratio and Severity of Carotid Artery Stenosis
- 1 April 2018
- Published by Elsevier in The American Journal of Cardiology
- Vol. 121 (8) , e56
The Relationship between Left Atrium Global Longitudinal Strain and Epicardial Fat Thickness in Patients with Paroxysmal Atrial Fibrillation
- 1 April 2018
- Published by Elsevier in The American Journal of Cardiology
- Vol. 121 (8) , e56
The Relationship between Left Atrium Global Longitudinal Strain and Epicardial Fat Thickness in Patients with Paroxysmal Atrial Fibrillation
- 1 June 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 117, S50
PP-021 Bilirubin Levels and Thrombus Burden in Patients with ST-elevation Myocardial Infarction
- 1 June 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 117, S50
PP-021 Bilirubin Levels and Thrombus Burden in Patients with ST-elevation Myocardial Infarction
- 1 June 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 117, S105-S106
PP-178 Total Bilirubin Levels Predict Subclinical Atherosclerosis in Patients with Prediabetes
- 1 June 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 117, S105-S106
PP-178 Total Bilirubin Levels Predict Subclinical Atherosclerosis in Patients with Prediabetes
- 1 January 2016
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 43 (4) , 333-9
Serum YKL–40/chitinase 3–like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome
The inflammatory process plays an important role in the development of cardiovascular complications in patients with obstructive sleep apnea syndrome (OSAS). YKL-40/chitinase 3-like protein 1 is a novel biomarker of systemic inflammation. This study aimed to investigate whether carotid intima-media thickness (CIMT), a useful marker for early atherosclerosis, is associated with serum YKL-40/chitinase 3-like protein 1 levels in patients with normotensive and nondiabetic OSAS. The study included 40 OSAS patients and 40 age- sex- and body mass index-matched healthy controls. Serum YKL-40 levels were detected by enzyme-linked immunosorbent assay. CIMT was measured by B-mode ultrasound. The patients with OSAS had significantly increased CIMT and higher YKL-40 and high sensitivity C-reactive protein (hsCRP) levels than those of the controls. CIMT was strongly correlated with serum YKL-40 levels (r=0.694, p<0.001), hsCRP (r=0.622, p<0.001), age (r=0.525, p=0.001), and weakly correlated with apnea-hypopnea index (AHI) (r=0.365, p=0.021) and the percentage of recording time spent (PRTS) of oxygen saturation<90% (r=0.488, p=0.001). Moreover, it was detected that serum YKL-40 levels were strongly correlated with AHI (r=0.617, p<0.001), and weakly correlated with SaO2<90% of PRTS (r=0.394, p=0.012) and hsCRP (r=0.486, p=0.001). In multiple regression analyses, age and serum levels of YKL-40 and hsCRP were found to be independent predictors of CIMT. In patients with OSAS, CIMT was increased. This increase was associated with serum YKL-40 level. Increased serum level of YKL-40 may be an early predictor of atherosclerosis development in patients with OSAS.
- 1 January 2016
- Published by Turkish Society of Cardiology in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Vol. 43 (4) , 333-9
Serum YKL–40/chitinase 3–like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome
The inflammatory process plays an important role in the development of cardiovascular complications in patients with obstructive sleep apnea syndrome (OSAS). YKL-40/chitinase 3-like protein 1 is a novel biomarker of systemic inflammation. This study aimed to investigate whether carotid intima-media thickness (CIMT), a useful marker for early atherosclerosis, is associated with serum YKL-40/chitinase 3-like protein 1 levels in patients with normotensive and nondiabetic OSAS. The study included 40 OSAS patients and 40 age- sex- and body mass index-matched healthy controls. Serum YKL-40 levels were detected by enzyme-linked immunosorbent assay. CIMT was measured by B-mode ultrasound. The patients with OSAS had significantly increased CIMT and higher YKL-40 and high sensitivity C-reactive protein (hsCRP) levels than those of the controls. CIMT was strongly correlated with serum YKL-40 levels (r=0.694, p<0.001), hsCRP (r=0.622, p<0.001), age (r=0.525, p=0.001), and weakly correlated with apnea-hypopnea index (AHI) (r=0.365, p=0.021) and the percentage of recording time spent (PRTS) of oxygen saturation<90% (r=0.488, p=0.001). Moreover, it was detected that serum YKL-40 levels were strongly correlated with AHI (r=0.617, p<0.001), and weakly correlated with SaO2<90% of PRTS (r=0.394, p=0.012) and hsCRP (r=0.486, p=0.001). In multiple regression analyses, age and serum levels of YKL-40 and hsCRP were found to be independent predictors of CIMT. In patients with OSAS, CIMT was increased. This increase was associated with serum YKL-40 level. Increased serum level of YKL-40 may be an early predictor of atherosclerosis development in patients with OSAS.